SHOP APOTHEKE EUROPE N.V. PUBLISHES CONVOCATION FOR ANNUAL GENERAL MEETING OF SHAREHOLDERS 2023 (ENGLISCH)

EQS-News: SHOP APOTHEKE EUROPE N.V. / Schlagwort(e): Hauptversammlung

SHOP APOTHEKE EUROPE N.V. PUBLISHES CONVOCATION FOR ANNUAL GENERAL MEETING

OF SHAREHOLDERS 2023 (ENGLISCH)

15.03.2023 / 18:34 CET/CEST

Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.

HINWEIS: DIESE MITTEILUNG IST NUR IN ENGLISCHER SPRACHE VERFÜGBAR.

NOT FOR DIRECT OR INDIRECT RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO

THE UNITED STATES OF AMERICA, CANADA, SOUTH AFRICA, AUSTRALIA OR JAPAN.

SHOP APOTHEKE EUROPE N.V. PUBLISHES CONVOCATION FOR ANNUAL GENERAL MEETING

OF SHAREHOLDERS 2023

Sevenum, 15 March 2023. SHOP APOTHEKE EUROPE N.V. ("SHOP APOTHEKE EUROPE" or

the "Company") has today published the convocation for the annual general

meeting of shareholders of the Company to be held on 26 April 2023 (the

"AGM").

The AGM materials (including the convocation notice, the agenda with the

explanatory notes thereto as well as other relevant documentation) are

available on the corporate website of the Company (

http://shop-apotheke-europe.com) under Investor Relations / General Meeting

/ Annual General Meeting 2023 and via the link:

http://shop-apotheke-europe.com/en/investorrelations/hauptversammlun g/

Among other things, shareholders at this year's AGM will vote on the

Company's name change, the appointment of a new CEO and the 2022 Annual

Report.

The AGM is scheduled to take place on 26 April 2023 starting at 10:00 CEST,

and will take place as a hybrid meeting, meaning that shareholders are given

the option to either participate in the AGM (i) in person at the Company's

headquarters, Erik de Rodeweg 11-13, Sevenum, the Netherlands or (ii)

virtually, through the online platform provided by the Company's service

provider Better Orange IR & HV AG (such platform the "Online Platform").

Taking into consideration that the Covid-19 virus may still pose a health

risk for shareholders and employees of the Company, the Company strongly

encourages its shareholders to take part in the AGM via the Online Platform

and not to attend the AGM in person.

For further information please contact us at:

General AGM related matters:

Rens Jan Kramer

Telephone: +31 6 46 18 67 23

Email: rensjan.kramer@shop-apotheke.com

Trade and public media:

Sven Schirmer

Mobile: +49 152 28 50 63 61

Email: presse@shop-apotheke.com

Financial media:

Thomas Schnorrenberg

Mobile: +49 151 46 53 13 17

Email: presse@shop-apotheke.com

15.03.2023 CET/CEST Veröffentlichung einer Corporate News/Finanznachricht,

übermittelt durch EQS News - ein Service der EQS Group AG.

Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.

Die EQS Distributionsservices umfassen gesetzliche Meldepflichten, Corporate

News/Finanznachrichten und Pressemitteilungen.

Medienarchiv unter https://eqs-news.com

Sprache: Deutsch

Unternehmen: SHOP APOTHEKE EUROPE N.V.

Erik de Rodeweg 11-13

5975 WD Sevenum

Niederlande

Telefon: 0800 - 200 800 300

Fax: 0800 - 90 70 90 20

E-Mail: Investor.Relations@shop-apotheke.com

Internet: www.shop-apotheke-europe.com

ISIN: NL0012044747, DE000A19Y072

WKN: A2AR94, A19Y07

Indizes: SDAX

Börsen: Regulierter Markt in Frankfurt (Prime Standard);

Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover,

München, Stuttgart, Tradegate Exchange

EQS News ID: 1583661

Ende der Mitteilung EQS News-Service

1583661 15.03.2023 CET/CEST

 ISIN  NL0012044747  DE000A19Y072

AXC0332 2023-03-15/18:34

Copyright dpa-AFX Wirtschaftsnachrichten GmbH. Alle Rechte vorbehalten. Weiterverbreitung, Wiederveröffentlichung oder dauerhafte Speicherung ohne ausdrückliche vorherige Zustimmung von dpa-AFX ist nicht gestattet.